Where does Noubar Afeyan work?

Noubar Afeyan is Founder and CEO at Flagship Pioneering and Board director at Moderna and Board director at Codiakbio and Board director at Cibo Technologies.

What check size does Noubar Afeyan write?

Noubar Afeyan typically writes checks of $500K – $15M.

What boards does Noubar Afeyan sit on?

Noubar Afeyan holds tracked board seats at BG Medicine, Cibo Technologies, Codiakbio, Moderna, Moderna, Pronutria Biosciences, Rubius Therapeutics, Seres Health.

Where did Noubar Afeyan go to school?

Noubar Afeyan studied at Massachusetts Institute of Technology (PhD, Biochemical Engineering); McGill University (BS, Chemical Engineering).

Noubar Afeyan

InvestorFounder

Founder and CEO at Flagship Pioneering · Board director at Moderna · Board director at Codiakbio · Board director at Cibo Technologies

Cambridge, Massachusetts, United States

Writes $500K – $15M checks

About

Noubar Afeyan runs a four‑phase company‑creation process that tests bad ideas with killer questions, numbers early projects for easy shutdown, and applies paranoid optimism shaped by his Armenian immigrant background.

Likely email· guessed from name + firm domain, not firm-published

n•••@flagshippioneering.comreveal100% confident

Invests in

AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech

Board director at Moderna

Intro paths

→

In turn, Noubar can intro founders to Moderna's investors below.

Moderna's investors · 7

Aglae VenturesParis · $108K – $5.4M checks · since 2016 Blackstone Life SciencesNew York · $20M – $60M checks · since 2016 Flagship PioneeringCambridge · $500K – $10M checks · since 2014 FPVJackson · $100K – $5M checks · since 2016 Khosla VenturesMenlo Park · $5K – $50M checks · since 2016 Premji InvestMenlo Park · since 2016 RA CapitalBoston · since 2016

Co-founders at Moderna

Robert LangerDirector

Board director at Codiakbio

Intro paths

→

In turn, Noubar can intro founders to Codiakbio's investors below.

Codiakbio's investors · 3

ARCH Venture PartnersChicago · $50K – $250M checks EcoR1 CapitalSan Francisco Flagship PioneeringCambridge · $500K – $10M checks · since 2015

Board director at Cibo Technologies

Intro paths

→

In turn, Noubar can intro founders to Cibo Technologies's investors below.

Cibo Technologies's investors · 3

Flagship PioneeringCambridge · $500K – $10M checks · since 2017 Generation Investment ManagementLondon Stage 1 VenturesCoconut Grove

Co-founders at Cibo Technologies

Bruno BassoCo-Founder and Special Advisor

Experience

Flagship PioneeringFounder and CEOcurrent2000 — presentCambridge, MA
Moderna TherapeuticsCo-Founder and Chairmancurrent2010 — present
Massachusetts Institute of Technology (MIT)Member of Executive Committee, MIT Corporationcurrent2016 — presentCambridge, MA
Generate Biomedicines, Inc.Co-Founder and Chairmancurrent2018 — presentCambridge, MA
Lila SciencesCo-founder/Founding Chairman, Board membercurrent2022 — presentCambridge, Massachusetts, United States
Aurora PrizeCo-Founder and Chairmancurrent2014 — presentYerevan, Armenia
Boston Symphony OrchestraMember Board of Trusteescurrent2008 — present
Tessera TherapeuticsCo-Founder and Board Member2018 — 2025Cambridge, MA
IndigoCo-Founder and Board Member2024 — 2025
Ampersand BiomedicinesCo-founder and Chairman2022 — 2024
Apriori BioCo-Founder and Chairman2021 — 2024Cambridge, MA
ProFound TherapeuticsCo-founder and Chairman2021 — 2024
Montai HealthCo-Founder and Board Member2019 — 2023
AlltrnaFounding Chairman2018 — 2023
Omega TherapeuticsCo-Founder and Chairman2016 — 2023Cambridge, MA
LarondeCo-Founder and Chairman2017 — 2022
Rubius TherapeuticsCo-Founder and Chairman2014 — 2022Cambridge, MA
Ring TherapeuticsCo-Founder and Chairman2018 — 2021
CellarityCo-Founder and Chairman2018 — 2021
Repertoire Immune MedicinesBoard Member and Co-Founder2016 — 2021Cambridge, Massachusetts, United States
Seres TherapeuticsCo-Founder and Board Member2011 — 2020Cambridge, MA
Sana Biotechnology, Inc.Board Member2019 — 2020
Harvard Business SchoolVisiting Lecturer2018 — 2020
Valo HealthFounding Chairman2018 — 2020
Cygnal TherapeuticsBoard Member and Co-Founder2016 — 2019
Kaleido Biosciences, Inc.Co-Founder and Board Member2015 — 2019
Evelo BiosciencesCo-Founder and Chairman2015 — 2019
Ohana Biosciences, Inc.Board Member2016 — 2018
AGBUBoard Member2014 — 2018
Axcella HealthChairman and Co-Founder2010 — 2018
CiBO TechnologiesCo-Founder and Board Member2015 — 2017Cambridge, MA
Codiak BioSciencesCo-Founder and Board Member2015 — 2017
Joule Unlimited Technologies, Inc.Chairman and Co-Founder2007 — 2017
MIT Sloan School of ManagementSenior Lecturer2000 — 2016
BG MedicineCo-Founder and Board Member2001 — 2016
Ensemble Therapeutics CorporationChairman and Co-Founder2002 — 2016
Midori Renewables, Inc.Board Member2010 — 2015Cambridge, MA
Eleven BiotherapeuticsBoard member2010 — 2014
AffinnovaBoard Member and Founder2002 — 2014
National Competitiveness Foundation of ArmeniaBoard Member2007 — 2014

Education

Massachusetts Institute of TechnologyPhD, Biochemical Engineering1983 — 1987
McGill UniversityBS, Chemical Engineering1980 — 1983

Skills & more

Entrepreneurship99Venture Capital99Lifesciences60Biotechnology95Product Innovation25Commercialization56Start-ups99Systems Biology46Hardware Diagnostics14Synthetic Biology18Visionary Thinking19Personalized Medicine35

From Noubar's professional profile.

Deals · 6

Rubius TherapeuticsBoard seat

via Flagship Pioneering · filed Jun 2017 · $120M raise

Cibo TechnologiesBoard seat

via Flagship Pioneering · filed Mar 2017 · $30.3M raise

Pronutria BiosciencesBoard seat

via Flagship Pioneering · filed Feb 2016

CodiakbioBoard seat

via Flagship Pioneering · filed Nov 2015

BG MedicineBoard seat

via Flagship Pioneering · filed May 2015 · $2.5M raise

Seres HealthBoard seat

via Flagship Pioneering · filed Jan 2015 · $65M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Moderna Moderna

Per SEC Form D filings.

Colleagues at Flagship Pioneering

Avak Kahvejian

General Partner at Flagship Pioneering

David Berry

General Partner at Flagship Pioneering

Geoffrey von Maltzahn

General Partner at Flagship Pioneering

Ignacio Martinez

General Partner at Flagship Pioneering

Network1

Brian Baynes

Co-Founder, Midori Health / Kaleido Biosciences & Founding Pillar at Pillar VC

Investors connected to Noubar in public investor directories — a warm-intro map.

Frequently asked questions

Who is Noubar Afeyan?: Noubar Afeyan runs a four‑phase company‑creation process that tests bad ideas with killer questions, numbers early projects for easy shutdown, and applies paranoid optimism shaped by his Armenian immigrant background.
Where does Noubar Afeyan work?: Noubar Afeyan is Founder and CEO at Flagship Pioneering and Board director at Moderna and Board director at Codiakbio and Board director at Cibo Technologies.
What does Noubar Afeyan invest in?: Noubar Afeyan invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, FoodTech, Healthtech.
What check size does Noubar Afeyan write?: Noubar Afeyan typically writes checks of $500K – $15M.
What boards does Noubar Afeyan sit on?: Noubar Afeyan holds tracked board seats at BG Medicine, Cibo Technologies, Codiakbio, Moderna, Moderna, Pronutria Biosciences, Rubius Therapeutics, Seres Health.
Where did Noubar Afeyan go to school?: Noubar Afeyan studied at Massachusetts Institute of Technology (PhD, Biochemical Engineering); McGill University (BS, Chemical Engineering).